Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group.
Ringdén O, Ruutu T, Remberger M, Nikoskelainen J, Volin L, Vindeløv L, Parkkali T, Lenhoff S, Sallerfors B, Ljungman P, et al. Ringdén O, et al. Among authors: sallerfors b. Blood. 1994 May 1;83(9):2723-30. Blood. 1994. PMID: 8167351 Free article. Clinical Trial.
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group.
Ringdén O, Remberger M, Ruutu T, Nikoskelainen J, Volin L, Vindeløv L, Parkkali T, Lenhoff S, Sallerfors B, Mellander L, Ljungman P, Jacobsen N. Ringdén O, et al. Among authors: sallerfors b. Blood. 1999 Apr 1;93(7):2196-201. Blood. 1999. PMID: 10090927 Free article. Clinical Trial.
No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group.
Ruutu T, Ljungman P, Brinch L, Lenhoff S, Lönnqvist B, Ringdén O, Ruutu P, Volin L, Albrechtsen D, Sallerfors B, Ebeling F, Myllylä G. Ruutu T, et al. Among authors: sallerfors b. Bone Marrow Transplant. 1997 Feb;19(3):233-6. doi: 10.1038/sj.bmt.1700649. Bone Marrow Transplant. 1997. PMID: 9028551 Clinical Trial.
Cytogenetic evolution patterns in CML post-SCT.
Karrman K, Sallerfors B, Lenhoff S, Fioretos T, Johansson B. Karrman K, et al. Among authors: sallerfors b. Bone Marrow Transplant. 2007 Feb;39(3):165-71. doi: 10.1038/sj.bmt.1705560. Epub 2007 Jan 8. Bone Marrow Transplant. 2007. PMID: 17211433
Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell support.
Johnsen HE, Björkstrand B, Carlson K, Gruber A, Blystad A, Fast A, Boesen AM, Björkholm M, Sallerfors B, Ruutu T, Carneskog J, Malm A, Geisler C, Lehtinen M, Schrøder H, Brinch L, Remes K, Tidefelt U, Heilmann C, Hörnsten P, Thorling K, Daugaard G. Johnsen HE, et al. Among authors: sallerfors b. Leuk Lymphoma. 1996 Dec;24(1-2):81-91. doi: 10.3109/10428199609045716. Leuk Lymphoma. 1996. PMID: 9049964
28 results